FDA 483 - Emergent Biodefense Operations Lansing LLC

An FDA inspection of Emergent BioSolutions in Lansing, MI, from September 30 to October 4, 2019, identified two significant observations. The firm was cited for inadequate segregation in a manufacturing area and the absence of a written procedure for the use and control of certain materials. These findings suggest deficiencies in facility control and procedural documentation.